Walgreens Boots Alliance
Walgreens Swings to Loss as COVID Hits Sales
The pandemic had an adverse impact on sales in the third quarter of about $700 million to $750 million though sales rose in the U.S.
Disclosures Amid COVID-19: “None of This Has Been Done Before”
Once the dust finally settles from the COVID-19 crisis, the last thing issuers will want is to face an inquiry and possible enforcement action by the SEC.
Big Health Care Companies Are Undervalued
McKesson and Walgreens are strong, healthy companies, despite recent downturns in their stock prices, a CEO in the investment field says.
Walgreens Stock Jumps 4% on Earnings Beat
“Following a difficult second quarter, we made progress in the third quarter against the strategic goals we set," CEO Stefano Pessina says.
Walgreens Slashes 2019 Outlook, Shares Dip 12%
The company's second-quarter report showed the continuing impact of shrinking generic drug sales on the country's largest pharmacy chains.
Why Amazon’s Stock Isn’t as Great as You Think
For CFOs wanting to understand investor behavior, here's an argument that Jeff Bezos is human, after all, and Amazon can't defy basic economic principles.
Pharmacy Sales Prescribe Growth for Walgreens
The drugstore chain's pharmacy same-store sales rose 5.1% in Q2, offsetting a 2.7% drop in retail comparable sales.
As core strategies for containing employee health-care costs diminish in effectiveness, companies need fresher approaches.
Rite Aid Misses Estimates, Comp Sales Drop
Prescription reimbursement rates "remain our largest challenge and we expect that to continue for the remainder of the fiscal year," the company says.